Beyond Air, Inc. (XAIR)

1.2300 +0.0300 (+2.50%) At close: 04:00PM EDT

Beyond Air, Inc.

900 Stewart Avenue
Suite 301
Garden City, NY 11530
United States
516 665 8200
https://www.beyondair.net

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 98

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Steven Adam Lisi	CEO & Chairman of the Board	650k	N/A	1971
Mr. Amir Avniel	Co-Founder, President, Chief Business Officer & Director	400k	N/A	1974
Mr. Michael A. Gaul	Chief Operating Officer	350k	N/A	1955
Mr. Douglas Quinton Larson	CFO, Principal Financial Officer & Principal Accounting Officer	274.95k	N/A	1971
Edward Barger	Head of Investor Relations	N/A	N/A	N/A
Ms. Kori-Ann Taylor	Head of Marketing	N/A	N/A	N/A
Dr. Andrew R. Colin M.D.	Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board	N/A	N/A	N/A
Dr. Jeff Myers M.D., Ph.D.	Chief Medical Officer	N/A	N/A	1965
Mr. Adam Newman	Corporate Secretary	250k	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Corporate governance

Beyond Air, Inc.’s ISS governance QualityScore as of 29 May 2024 is 9. The pillar scores are Audit: 7; Board: 10; Shareholder rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.